Evidence map›Paper›PMID 34037843›Full record

ReviewApplied microbiology and biotechnology2021

Research progress on gut microbiota in patients with gastric cancer, esophageal cancer, and small intestine cancer.

Changchang Chen, Linjie Chen, Lijun Lin, Dazhi Jin, Yaoqiang Du, Jianxin Lyu

Abstract readReview
PubMed Publisher
In one paragraph

Review in Applied microbiology and biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Investigating the role of inflammatory cytokines in mediating the effect of gut microbiota on gastrointestinal cancers: a mendelian randomization study.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2025
    Article
  7. Intratumoral microbiota: a new force in the development and treatment of esophageal cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  8. Article
  9. Article
  10. IsWorld journal of gastroenterology · 2024
    Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Progress of gut microbiome and its metabolomics in early screening of colorectal cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Changchang ChenSchool of Laboratory Medicine, Hangzhou Medical College, Zhejiang, 310053, Hangzhou, China.
Linjie ChenSchool of Laboratory Medicine, Hangzhou Medical College, Zhejiang, 310053, Hangzhou, China.
Lijun LinSchool of Basic Medicine and Forensic Medicine, Hangzhou Medical College, Zhejiang, 310053, Hangzhou, China.
Dazhi JinSchool of Laboratory Medicine, Hangzhou Medical College, Zhejiang, 310053, Hangzhou, China.
Yaoqiang DuResearch Center of Blood Transfusion Medicine, Education Ministry Key Laboratory of Laboratory Medicine, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Zhejiang, 310014, Hangzhou, China. duyaoqiang524@126.com.
Jianxin LyuSchool of Laboratory Medicine, Hangzhou Medical College, Zhejiang, 310053, Hangzhou, China. ljx@hmc.edu.cn.ORCID http://orcid.org/0000-0001-9892-6802

Funding

Medicine and Health Research Foundation of Zhejiang Province 2019RC012National Natural Science Foundation of China 81830071Natural Science Foundation of Zhejiang Province (CN) LQ21H200007
6 · The paper itself

Abstract

The pathogenesis of gut microbiota in humans can be indicated due to the wide application of techniques, such as 16S rRNA sequencing. Presently, several studies have found a significant difference in fecal flora between normal individuals and patients with gastric cancer. Although clinical research on the feedback mechanism of gastric flora and gut microbiota is lacking, clarifying the relationship between gut microbiota and the characteristics of cancer is significant for the early diagnosis of gastric cancer. This study was conducted to review the results of several studies in the past 5 years and analyze the intestinal bacteria in patients with gastric cancer and compare them with those in patients with esophageal and small intestine cancers. It was found that the gut microbiota in patients with gastric cancer was similar to that in patients with esophageal cancer. However, making an analysis and comparing the gut microbiota in patients with small intestine and gastric cancers was impossible due to the low incidence of small intestinal cancer. Our review summarized the research progress on using the gut microbiota for early screening for gastric cancer, and the results of this study will provide a further direction in this field. KEY POINTS: • We reviewed several relative mechanisms of the gut microbiota related to gastric cancer. • The gut microbiota in gastric, esophageal, and small intestine cancers are significantly different in types and quantity, and we have provided some tips for further research. • A prospective review of sequencing methods and study results on the gut microbiota in gastric, esophageal, and small intestine cancers was described.

Indexed as

Esophageal NeoplasmsGastrointestinal MicrobiomeStomach NeoplasmsHumansIntestine, SmallProspective StudiesRNA, Ribosomal, 16SRNA, Ribosomal, 16S16S rRNAEsophageal cancerGastric cancerGut microbiotaSmall intestine cancer

Identifiers

PMID34037843

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.